FRCS (Neuro.Surg) Edinburgh - 2009. PhD (Neuroscience) Liverpool - 2007. MB ChB (Honours) Liverpool - 1998. BSc Physiology (1st class) - 1996.
University of Liverpool Medical School: 1992-1998
Mersey Deanery Neurosurgical Training Programme: 2001-2003. Clinical Research Fellowship: 2003-2006. Mersey Deanery Neurosurgical Training Programme: 2006-2010.
Clinical Senior Lecturer in Neurosurgery. University of Liverpool: 2015 - present. NCRI Brain Tumour CSG member: 2013 - present. Associate Editor British Journal of Neurosurgery: 2013 - present. Member of SBNS academic committee: 2015 - present.
Society of British Neurological Surgeons. British Neuro-Oncology Society. Society for Neuro-Oncology. European Association of Neuro-Oncology.
Neuro-oncology including awake craniotomy, intraventricular tumours, pineal tumours. Hydrocephalus including endoscopy.
Chair of Neuro-oncology Multidisciplinary Team. Chair of hospital morbidity and mortality committee.
Research interests include: • the application of advanced MRI to routine clinical neuro-oncology • non-invasive tumour biomarkers • clinical trials in neurosurgery Grant income: 1. Investigation of local brain invasion by cerebral metastases and implications for clinical management MRC PhD fellowship awarded to Rasheed Zakaria (March 2014): £146,323. Chief Investigator. 2. Radiation versus Observation following surgical resection of Atypical Meningioma: a randomised controlled trial (The ROAM Trial). NIHR HTA (January 2014): £1.37million. Chief Investigator. 3. The British Antibiotic and Silver Impregnated Catheters for ventriculoperitoneal Shunt multi-centre randomised controlled trial (The BASICS Trial). NIHR HTA (June 2012): £2.04 million. Co-Chief Investigator. 4. Ketogenic trials as adjuvant therapy for glioblastoma (The KEATING Trial). Vitaflow (Sept 2016): £195,323.
1. Zakaria R, Das K, Radon M, Bhojak M, Rudland PR, Slumming V, Jenkinson MD. Diffusion-weighted MRI characteristics of the cerebral metastasis to brain boundary predicts patient outcomes. BMC Medical Imaging 2014 14(1): 26. Doi 10.1186/1471-2342-14-26 2. Zakaria R, Das K, Bhojak M, Radon M, Slumming V, Walker C, Jenkinson MD. The reliability of routine clinical post-processing software in assessing potential diffusion weighted MRI “biomarkers” in brain metastases. Magnetic Resonance Imaging 2014 32(3): 291-296 3. Jenkinson MD, Gamble C, Hartley JC, Hickey H, Hughes D, Blundell M, Griffiths MG, Solomon T, Mallucci CL. The British antibiotic and silver-impregnated catheters for ventriculoperitoneal shunts multi-centre randomised controlled trial (the BASICS trial): study protocol. Trials 2014 15(4): doi: 10.1186/1745-6215-15-4 4. Jenkinson MD, Weber DC, Haylock BJ, Mallucci CL, Zakaria R, Javadpour M . Atypical meningioma: current clinical dilemmas and prospective clinical trials. Journal of Neurooncology 2014 (In press): 5. Zakaria R, Das K, Bhojak M, Radon M, Slumming V, Walker C, Jenkinson MD. The role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosis. Cancer Imaging 2014 (In press):
Understanding activity pie charts
What does the Consultant activity pie chart show?
The Consultant activity pie charts represent the total number of elective (planned) finished consultant episodes (FCEs) and non-elective (emergency) finished consultant episodes. A finished consultant episode usually represents the care of a single patient from admission to discharge.
Please note that for Consultants who provide both adult services for patients older than 17 years and paediatric services for patients 16 years old and younger there are two outcome reports.
Understanding mortality funnel plot charts
What does the Consultant funnel plot chart show?
The Hospital Consultant mortality funnel plot represent the total number of elective (planned) finished consultant episodes (FCEs) and non-elective (emergency) finished consultant episodes. A finished consultant episode usually represents the care of a single patient from admission to discharge.
The mortality presented here is for three years: April 2014 – March 2017. Please note that for Consultant who provide both adult services for patients older than 17 years and paediatric services for patients 16 years old and younger there are two outcome reports.
The horizontal yellow line represents the national average mortality. The solid black lines above and below the yellow line are the control limits. The upper control limit represents the highest expected mortality rate. The Consultant's outcome is highlighted in magenta.